The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
News
Services
Subscribe
Advertise
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Rights & permissions
Contact us
Author centre
Bernhard Meier
Showing 21-40 of 43 articles
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
Meier B,
Blaauw Y,
Khattab A,
Lewalter T,
Sievert H,
Tondo C,
Glikson M
January 22, 2015 | 10.4244/EIJY14M09_18
Extent and distribution of calcification of both the aortic annulus and the left ventricular outflow tract predict aortic regurgitation after transcatheter aortic valve replacement
Buellesfeld L,
Stortecky S,
Heg D,
Gloekler S,
Meier B,
Wenaweser P,
Windecker S
October 20, 2014 | 10.4244/EIJV10I6A126
Long-term comparison of everolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for percutaneous coronary intervention of saphenous vein grafts
Taniwaki M,
Räber L,
Magro M,
Kalesan B,
Onuma Y,
Stefanini G,
van Domburg R,
Moschovitis A,
Meier B,
Jüni P,
Serruys P,
Windecker S
April 22, 2014 | 10.4244/EIJV9I12A241
Impact of stent overlap on long-term clinical outcomes in patients treated with newer-generation drug-eluting stents
O’Sullivan C,
Stefanini G,
Räber L,
Heg D,
Taniwaki M,
Kalesan B,
Pilgrim T,
Zanchin T,
Moschovitis A,
Büllesfeld L,
Khattab A,
Meier B,
Wenaweser P,
Jüni P,
Windecker S
January 20, 2014 | 10.4244/EIJV9I9A182
Severe aortic stenosis and coronary artery disease
Stefanini G,
Stortecky S,
Meier B,
Windecker S,
Wenaweser P
September 15, 2013 | 10.4244/EIJV9SSA12
Effect of pressure-controlled intermittent coronary sinus occlusion (PICSO) on myocardial ischaemia and reperfusion in a closed-chest porcine model
Khattab A,
Stieger S,
Kamat P,
Vandenberghe S,
Bongoni A,
Stone G,
Seiler C,
Meier B,
Hess O,
Rieben R
July 26, 2013 | 10.4244/EIJV9I3A63
Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents
Pilgrim T,
Kalesan B,
Zanchin T,
Pulver C,
Jung S,
Mattle H,
Carrel T,
Moschovitis A,
Stortecky S,
Wenaweser P,
Stefanini G,
Räber L,
Meier B,
Jüni P,
Windecker S
January 18, 2013 | 10.4244/EIJV8I9A163
The Titan stent, just a good bare metal stent or more?
Baur H-R,
Meier B
July 27, 2012 | 10.4244/EIJV8I3A46
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design
Räber L,
Kelbæk H,
Ostojic M,
Baumbach A,
Tüller D,
von Birgelen C,
Roffi M,
Pedrazzini G,
Kornowski R,
Weber K,
Heg D,
Matter C,
Lüscher T,
Taniwaki M,
Meier B,
Jüni P,
Windecker S
April 20, 2012 | 10.4244/EIJV7I12A224
Clinical long-term outcome after implantation of titanium nitride-oxide coated stents compared with paclitaxel- or sirolimus-eluting stents: propensity-score matched analysis
Limacher A,
Räber L,
Laube E,
Lauterburg A,
Lötscher S,
Hess N,
Moschovitis A,
Baldinger S,
Wenaweser P,
Meier B,
Hess O,
Jüni P
January 20, 2012 | 10.4244/EIJV7I9A166
Clinical outcomes after PCI for acute coronary syndrome in unprotected left main coronary artery disease: insights from the Swiss Acute Left Main Coronary Vessel Percutaneous Management (SALVage) study
Puricel S,
Adorjan P,
Oberhänsli M,
Stauffer J-C,
Moschovitis A,
Vogel R,
Goy J-J,
Muller O,
Eeckhout E,
Togni M,
Wenaweser P,
Meier B,
Windecker S,
Cook S
October 28, 2011 | 10.4244/EIJV7I6A112
Impact of coronary artery disease and percutaneous coronary intervention on outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation
Wenaweser P,
Pilgrim T,
Guérios E,
Stortecky S,
Huber C,
Khattab A,
Kadner A,
Buellesfeld L,
Gloekler S,
Meier B,
Carrel T,
Windecker S
September 30, 2011 | 10.4244/EIJV7I5A89
Tools & Techniques: PFO/ASD closure
Pavlovic M,
Buellesfeld L,
Meier B
July 29, 2011 | 10.4244/EIJV7I3A66
In memoriam Otto Martin Hess, MD
Meier B
May 17, 2011 | 10.4244/EIJV7I1A1
The outcome of bifurcation lesion stenting using a biolimuseluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer
Garg S,
Wykrzykowska JJ,
Serruys P,
de Vries T,
Buszman P,
Trznadel S,
Linke A,
Lenk K,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
Tyczynski P,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
March 21, 2011
Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study
Eshtehardi P,
Cook S,
Wandel S,
Räber L,
Wenaweser P,
Togni M,
Vogel R,
Garachemani A,
Eberli F,
Lüscher T,
Jüni P,
Hess O,
Meier B,
Windecker S
September 30, 2010
Percutaneous coronary interventions in Europe in 2006
Moschovitis A,
Cook S,
Meier B
June 30, 2010 | 10.4244/EIJV7I6A31
The twelve-month outcomes of a biolimus eluting stent with a biodegradable polymer compared with a sirolimus eluting stent with a durable polymer
Garg S,
Sarno G,
Serruys P,
de Vries T,
Buszman P,
Linke A,
Ischinger T,
Klauss V,
Eberli F,
Corti R,
Wijns W,
Morice M,
Di Mario C,
van Geuns R,
Eerdmans P,
Van Es G-A,
Meier B,
Jüni P,
Windecker S
June 30, 2010
Randomised comparison of titanium-nitride-oxide coated stents with bare metal stents: five year follow-up of the TiNOX trial
Moschovitis A,
Simon R,
Seidenstücker A,
Klauss V,
Baylacher M,
RN R,
Lüscher T,
Moccetti T,
Windecker S,
Meier B,
Hess O
May 25, 2010
Have we been misled by the ESC DES firestorm?
Cook S,
Meier B
March 20, 2008
1
2
3
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke